Adaptin Bio

Public

Adaptin Bio is now publicly traded

The data on this page reflects Adaptin Bio's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Convertible Debt

Mar 23, 2026

Total Funding Raised

$1.65M

Company Overview

Adaptin Bio Operating Corporation is a biotechnology company that develops novel therapies for oncology and central nervous system disorders with improved drug delivery to the brain and other tissues.

AI Layer

Non-AI

Keywords

blood-brain barrier deliveryBRiTE platformglioblastoma multiformeGBMT-cell engagerdrug delivery platformimmunotherapyimmuno-oncologyCNS drug deliverycell therapybispecific antibodiesbrain cancer treatmentoncology therapeuticsclinical-stage companycentral nervous system disordersCNS

Adaptin Bio Comparables

Compare Adaptin Bio with similar companies based on industry and business-model similarity.

Adaptin Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Mesenkia Therapeutics AB	81%

View all Comparables

Adaptin Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Convertible Debt	Mar 23, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Roberts

Chief Executive Officer

Executive Team

Adaptin Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Adaptin Bio Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range3

Year Founded2021

Last FundingMar 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?